Clinical Trials Browser

Phase EARLY_PHASE1 × Recruiting × Retinoblastoma × Clear all

NCT06424301 2025-06-26

Targeting NUDT21 siRNA Drugs for Patients With Refractory Retinoblastoma

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Retinoblastoma

NCT06972602 2025-05-15

High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous Seed

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Recurrence, Retinoblastoma